Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An eight-week, randomized, double-blind, parallel group, multicenter, dose escalation study to evaluate the efficacy and safety of aliskiren administered alone and in combination with ramipril in patients with hypertension and diabetes mellitus https://kusajili.fr:443/Trial/wyVz7tZwhE6wMIqYpgYBNA%24an-eight-week-randomized-double-blind-parallel-group-multicenter-dose-escalation-study-to-evaluate-the-efficacy-and-safety-of-a
I have read and accept the terms of use of the site and the Privacy Policy
Send your message